CompanyGraph
At a glance
- Depends onMidstream position: 6 outgoing, 8 incoming connections
- PositionGross margin is 23.8%, lower than 95% of its Medical Devices peers (median 61%)
- FinancialsLow earnings quality
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.27%Below 5Y avg (1.50%)
Annual Rate
CNY 0.05Paid annual
Payout Ratio
0.0%Sustainable
Last Ex-Dividend
Nov 26, 2025
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
4.92BCNY730.18M · vs all stocks (USD)
Revenue (TTM)
1.10BCNY162.69M · vs all stocks (USD)
Profit Margin
-6.34%vs Medical Devices peers
52-Week Change
93.54%vs all stocks
Market Capitalization
4.92BCNY730.18M · vs all stocks (USD)
Enterprise Value
5.11BCNY759.47M · vs all stocks (USD)
Forward P/E
26.90xvs Medical Devices peers
Price to Sales (TTM)
4.42xvs Medical Devices peers
Price to Book (MRQ)
4.23xvs Medical Devices peers
Enterprise to Revenue
4.67xvs Medical Devices peers
Enterprise to EBITDA
99.72xvs Medical Devices peers
Gross Margin
23.81%vs Medical Devices peers
Profit Margin
-6.34%vs Medical Devices peers
Operating Margin
0.36%vs Medical Devices peers
Return on Assets (TTM)
-0.42%vs Medical Devices peers
Return on Equity (TTM)
-5.23%vs Medical Devices peers
Revenue (TTM)
1.10BCNY162.69M · vs all stocks (USD)
Revenue per Share (TTM)
4.14CNYUpdated Aug 19, 2026Quarterly Revenue Growth
-1.90%vs Medical Devices peers
Gross Profit (TTM)
281.53MCNY41.81M · vs all stocks (USD)
EBITDA (TTM)
60.34MCNY8.96M · vs all stocks (USD)
Net Income (TTM)
-69.43MCNY-10.31M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-3.94%vs Medical Devices peers
Operating Cash Flow (TTM)
90.44MCNY13.43M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-124.08MCNY-18.43M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.0500CNYUpdated Aug 19, 2026Trailing Annual Dividend Yield
0.27%vs all stocks
5-Year Average Dividend Yield
1.50%vs all stocks
Payout Ratio
0.00%vs Medical Devices peers
Minority Interest (Equity)
74.65MCNYFY2025 · Dec 31, 2025Revenue
1.10BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
813.86MCNYFY2025 · Dec 31, 2025Gross Profit
281.53MCNYFY2025 · Dec 31, 2025Operating Income
-16.76MCNY-2.49M · vs all stocks (USD)
Pre-tax Income
-76.30MCNYFY2025 · Dec 31, 2025Income Tax Expense
-10.89MCNYFY2025 · Dec 31, 2025Net Income
-65.41MCNYFY2025 · Dec 31, 2025EBIT
-48.68MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
60.34MCNYFY2025 · Dec 31, 2025Research & Development
69.68MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
111.51MCNYFY2025 · Dec 31, 2025Other Operating Expenses
7.88MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
13.94MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
27.62MCNYFY2025 · Dec 31, 2025EPS (Basic)
-0.2624CNYFY2025 · Dec 31, 2025EPS (Diluted)
-0.2624CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
264.59MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
264.59MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-65.41MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-4.02MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-287.44MCNYFY2025 · Dec 31, 2025Free Cash Flow
-442.25MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
661.80MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-65.41MCNYFY2025 · Dec 31, 2025Other Non-cash Items
42.87MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-186.80MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-78.11MCNYFY2025 · Dec 31, 2025Capital Expenditures
-154.81MCNYFY2025 · Dec 31, 2025Purchase of Investments
-89.00MCNYFY2025 · Dec 31, 2025Sale of Investments
340.31MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
96.51MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
371.50MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-304.08MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-30.65MCNYFY2025 · Dec 31, 2025Other Financing Charges
5.52MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
42.30MCNYFY2025 · Dec 31, 2025Shares Outstanding
264.61MSharesUpdated Aug 19, 2026Float Shares
182.93MSharesUpdated Aug 19, 2026% Held by Insiders
31.60%vs all stocks
% Held by Institutions
2.71%vs all stocks
Total Cash (MRQ)
577.33MCNY85.75M · vs all stocks (USD)
Total Cash per Share (MRQ)
2.21CNYUpdated Aug 19, 2026Total Debt (MRQ)
665.68MCNY98.87M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.5522xvs Medical Devices peers
Current Ratio (MRQ)
1.59xvs Medical Devices peers
Book Value per Share (MRQ)
4.32CNYUpdated Aug 19, 2026Total Assets
2.52BCNY374.61M · vs all stocks (USD)
Total Current Assets
1.28BCNYFY2025 · Dec 31, 2025Total Liabilities
1.31BCNYFY2025 · Dec 31, 2025Total Non-current Assets
1.25BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
507.58MCNYFY2025 · Dec 31, 2025Total Current Liabilities
802.54MCNYFY2025 · Dec 31, 2025Cash
665.61MCNYFY2025 · Dec 31, 2025Cash Equivalents
11.34MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
676.95MCNYFY2025 · Dec 31, 2025Accounts Receivable
242.14MCNYFY2025 · Dec 31, 2025Inventory
287.82MCNYFY2025 · Dec 31, 2025Accounts Payable
224.01MCNYFY2025 · Dec 31, 2025Short-term Debt
397.60MCNYFY2025 · Dec 31, 2025Other Current Liabilities
9.31MCNYFY2025 · Dec 31, 2025Long-term Debt
327.21MCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
1.04MCNYFY2025 · Dec 31, 2025Common Stock (Book)
264.58MCNYFY2025 · Dec 31, 2025Retained Earnings
352.77MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
1.21BCNY180.03M · vs all stocks (USD)
Treasury Stock
20.01MCNYFY2025 · Dec 31, 202552-Week Low
7.67CNYUpdated Aug 19, 202652-Week High
21.98CNYUpdated Aug 19, 202652-Week Change
93.54%vs all stocks
50-Day MA
16.75CNYUpdated Aug 19, 2026200-Day MA
14.10CNYUpdated Aug 19, 2026Avg 10-Day Volume
16.58MSharesUpdated Aug 19, 2026Avg 30-Day Volume
14.62MSharesUpdated Aug 19, 2026Diluted EPS (TTM)
-0.3400CNYUpdated Aug 19, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Gross margin is 23.8%, lower than 95% of its Medical Devices peers (median 61%)Significant
Gross margin: 0.24Industry median: 0.61Industry P5: 0.28Peers compared: 102
Financial Health
Low earnings qualitySignificant
Earnings Quality Score: -0.57
Altman Z-Score 3.04: safe zoneNotable
Altman Z-Score: 3.04
Supply Chain
Midstream position: 6 outgoing, 8 incoming connectionsNotable
Outgoing: 6.00Incoming: 8.00
High connectivity hub: 14 industry connectionsNotable
Total Connections: 14.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Immix Biopharma Inc.
Tier 1ProductionApproval-Gated PipelineRule
SS Innovations International, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Senores Pharmaceuticals Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Getein Biotech Inc.
Tier 1ProductionApproval-Gated PipelineRule
Climb Biotherapeutics, Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Yabao Pharmaceutical Group Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Oculis Holding AG
Tier 1ProductionApproval-Gated PipelineRule
Shanghai Sanyou Medical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Zhuzhou Qianjin Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Aura Biosciences Inc.
Tier 1ProductionApproval-Gated PipelineRule